Please assess the completion status of the following clinical trial:

Trial Title: Monitoring of Patients Followed for a Multiple Sclerosis and Treated by Dimethyl-fumarate

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* patient 18 years old and more~* with multiple sclerosis according to the criteria of Mac Donald 2010 : relapsing-remitting (RR), secondary-progressive (SP) or primary-progressive (PP)~* for which treatment with dimethyl-fumarate has been prescribed~* followed at the Rothschild Foundation in the Neurology Department~* having given written consent to participation in the study~Exclusion Criteria:~* pregnant or breastfeeding woman~* patient with a measure of legal protection~* subject unaffiliated insurance

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Patient with recurring-remitting MS (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).